Primary goal of attending an international conference is to present a paper to the experts and influencers. It gives you a platform to exchange your interest-related thoughts, paving the way for possible future collaborations.
Use this platform to build connections with an elite group of wise men and women to enhance your intellect. Young entrepreneurs, this is a great platform to connect with your peers.
Knowledge is Power. Knowledge teaches skills. Skills define excellence. Use this platform to become cognizant of your interest area to achieve excellence in your domain.
Attending a conference give you opportunity to get your abstract or paper published in conference proceedings
Meet and greet a myriad of industry professionals and academia experts with common interest. Every meal will be an opportunity to meet and interact with fellow researchers, attendees and experts.
Expand your professional competency and learn useful tips and tricks of your industry in our skill-building workshops.
Explore insights on recent advancements, new equipment, new techniques, and unpublished data, learn from thought-leaders and get to network with a great line up of speakers.
Our exhibits floor offers the attendees with a dynamic display of the latest products with cutting-edge technology.
Investing in you is the best investment. Peers Alley conferences give the patrons with a feeling of the serendipity of real learning, skill development in strategic workshops, networking and start-up opportunities, thus, is value for money.
Attending the conference gives you much needed break from your regular duties. It also allows you to explore new cities, culture and meet new people. You will feel energized and rejuvenated to return to the university and continue with the job after attending the conference.
Conferences are vital forum for academic researchers and business leaders. "It involves multiple presentations, interactive breakout sessions, hands-on product demonstrations and unrivalled networking opportunities".
We have invited some of the world's most sought-after keynote speakers, experts, brand ambassadors, and industry leaders to share their thoughts and ideas with our conference guests.Register Now
Dear Colleagues and Friends
It gives us a great pleasure to invite you to participate in the “International Congress on Advanced Cardiology and Cardiovascular Research” which is going to be held in beautiful city Paris, France during March 30-31, 2022. This conference bids an unparalleled opportunity to network with colleagues and learn from the distinguished leaders in cardiology and cardiovascular research.
This conference is an exceptional and leading event ardent to the science with practice of cardiology and cardiovascular research, which makes a perfect platform for global networking as it brings together the renowned speakers, professors, scientists, educationalists, researchers and students across the globe to a most exciting and memorable scientific meeting to report and witness the latest scientific breakthroughs in cardiology in broad range of scientific fields.The planning committee has designed a comprehensive program features the best in cardiology, and cardiovascular clinical practice.about AdvCardiology 2022 conference
As a member of Peers Alley Media, I am pleased to welcome you all to the conference “International Congress on Advanced Cardiology and Cardiovascular Research”.
Cardiology conference will provide a platform for scientists, world-class professors, researchers and cardiologists to discuss on multiple types of cardiac diseases, diagnosis, therapy of cardiac illnesses and prevention. In recent years, cardiac and vascular devices have been developed to assist mankind in the treatment, replacement and repair therapy of cardiac disorders.
As the largest cardiology conference in Europe region, it is expected to bring more than 300+ experts, cardiologists, radiologists, physicians, surgeons, vascular medicine specialists, industrial partners, other health care professionals and many more…..!
Adv.Cardiology 2022 will also provide a unique opportunity for the industries to exhibit and showcase their new products, devises, and medical instruments and to contact with the cardiologists more closely.
The benefits provided to the attendees are:
Welcome to Paris and we look forward to your active participations in our most existing event Adv.Cardiology 2022, may I wish you a very pleasant and entertaining stay in Paris, France.
University of Newcastle, Australia
Thomas Lord Professor of Engineering in the Edmund T. Pratt, USA
Chief Medical Officer, Catholic Health Services (CHS), USA
Cardiologists are doctors who are specialized in cardiovascular system disease diagnosis and treatment.
It is necessary in the United States to complete four years of medical school, three years of internal medicine training, and at least three years of cardiology specialization.
Cardiac diseases that can be helped by a cardiologist, including: atherosclerosis, atrial fibrillation, arrhythmias, congenital heart disease, heart disease, congestive heart disease, high blood cholesterol and triglycerides, hypertension, pericarditis, ventricular tachycardia and hypertension.
A cardiologist will review the medical history of a patient and perform certain physical tests such as: electrocardiogram (ECG or EKG), ambulatory ECG, echocardiogram, cardiac catheterization, and nuclear cardiology.
General clinical cardiologists | Electro physiologist | Nuclear cardiologists | MR/CT cardiologists | Pediatric cardiologists | Heart failure & transplant cardiologist | Preventive cardiologists | Vascular medicine specialists | Cardiovascular investigators | Cardiac anesthesiologists
The cardiology Surgical & Interventional Cardiology Devices Market was valued at $ 17.95 billion in 2019 and is expected to grow at a CAGR of 7.65% between 2020 and 2025.
Atherosclerosis Conferences Cardiology Conferences 2022 Japan Geriatric Cardiology Conferences Clinical Cardiology Conferences Nuclear Cardiology Conferences Cardiac Imaging Conferences Cardiology Conferences 2022 Cardiovascular Pharmacology Conferences Thrombosis Conferences Cardiology Case Reports Conferences Cardiac Regeneration Conferences Cardiologist Conferences Heart Diseases in Woman Conferences Sports Cardiology Conferences Peers Alley Media Conferences
Clinical cardiologists are trained physicians whose cardiac disease research include: congenital heart disease, coronary artery disease, valvular heart disease, heart failure and epidemiology, pathophysiology, aetiology, and genetics.
Special attention should be paid to studies involving the diagnosis, treatment and management of cardiac disorders such as: electrophysiology, cardiac medicine, cardiovascular implants, cardiac surgery, cardiac reconstruction and cardiovascular risk factors detection.
A professional cardiologist specializes in treating congenital heart disorders, endocarditis, pericarditis, high blood pressure and heart rhythms that are abnormal.
The pay is quite high for professional cardiologists, with a median salary of $316,000 for non-invasive surgeons.
Cardiovascular medicine | Preventive medicine | Sleep medicine | Percutaneous Coronary Intervention (PCI) | Modern practices in cardiovascular therapy
The global cardiovascular market is approximately $259.1 billion, of which $187 billion is for therapy and $72.1 billion is for devices. The cardiovascular market in the United States is approximately $81.35 billion, with therapy accounting for $50.49 billion and equipment accounting for $30.86 billion.
Cardiac Surgery Conferences Geriatric Cardiology Conferences Cardio-Oncology Conferences Robotic Cardiac Surgery Conferences Stroke Conferences Cardiac Regeneration Conferences Cardiology Conferences 2022 Australia Interventional Cardiology Conferences Peers Alley Media Conferences Acute Coronary Syndromes Conferences Hypertension Conferences Cardiac Nursing Conferences Thrombosis Conferences Atherosclerosis Conferences Cardiology Conferences 2022 Canada
Cardiovascular disease or heart disease due to a variety of conditions, including coronary artery disease, heart rhythm (arrhythmias) and congenital heart defects.
There are two types of heart disease. Congenital disease of the heart 2. Cardiovascular disease acquired from heart disease describes the heart or blood vessel disease. Cardiovascular disease includes heart disease, stroke, heart failure, rheumatic heart disease, heart disease, cardiomyopathy, congenital heart disease, heart arrhythmia, heart disease, carditis, thromboembolic disease, aortic aneurysms, peripheral artery disease, and venous thrombosis.
Older adults are affected by most cardiovascular disease. In the United States, 11 percent of people aged 20 to 40 have CVD, while 37 percent of people aged 40 to 60 have CVDs, 71 percent of people aged 60 to 80 have CVDs, and 85 percent of people aged 80.
Coronary artery diseases | Atrial fibrillation | Angina | Heart attack | Ischemia heart disease | Cerebrovascular disease | Inflammatory heart disease
From $12.2 billion in 2014 to $22.5 billion in 2021, the market for technologies and goods used to treat coronary heart disease is expected to expand.
Cardiology Conferences 2022 Europe Electrocardiography Conferences Cardiology Conferences 2022 Asia Peers Alley Media Conferences Geriatric Cardiology Conferences Thrombosis Conferences Dyslipidemia Conferences Cardiology Conferences 2022 Cardiology Conferences Cardiology Conferences 2022 Canada Vascular Biology Conferences Cardio-Oncology Conferences Arrhythmia Conferences Cardiologist Conferences Myocardial Infarction Conferences
Hypertension is commonly referred to as hypertension (HBP). In which the arteries ' blood pressure is persistently elevated. A major risk factor for coronary artery disease, heart failure, stroke, atrial fibrillation, vision loss, peripheral vascular disease, chronic kidney disease, and dementia, is this long-term medical condition.
High blood pressure is graded as primary high blood pressure:· Approximately 90-95 percent of primary high blood pressure cases· Non-specific lifestyle, genetic factors, excess body weight, smoking, and alcohol are the main reasons for secondary high blood pressure:· Approximately 5-10 percent of secondary high blood pressure cases·
Hypertension can cause seizures, failure to thrive, irritability, reduced energy, and difficulty breathing in newborns and young infants. Hypertension can cause headache, unexplained irritability, failure to thrive, tiredness, nosebleeds, blurred vision, and facial paralysis in older infants and children.
Key hypertension prevention:· maintain normal adult body weight· minimize dietary sodium intake· require moderate physical activity· regulate alcohol consumption· raise the intake of fruit and vegetables
Hypertension | Pulmonary Hypertension | Pediatric Hypertension | Gestational Hypertension | Resistant Hypertension | Sexual dysfunction in Hypertensive patients | Hypertension in diabetes patients | Renal hypertension | Hypertensive heart diseases | Stroke in Hypertensive patients | Obesity in Hypertensive patients | Hypertension Risk Factors, Diagnosis and Treatment | Hypertension Epidemiology | Cardiology | Cardiovascular disease
The hypertension market is the largest among the various heart disorders, accounting for $32 billion in prescription drug sales in 2018. The market is predicted to increase at a CAGR of 1.7% from 2018 to 2028.
Cardiology Conferences 2022 Canada Myocardial Infarction Conferences Cardiovascular Pharmacology Conferences Arrhythmia Conferences Cardiology Conferences 2022 Japan Peers Alley Media Conferences Dyslipidemia Conferences Acute Coronary Syndromes Conferences Hypertension Conferences Robotic Cardiac Surgery Conferences Stroke Conferences Nuclear Cardiology Conferences Cardiac Imaging Conferences Cardiology Conferences 2022 Clinical Cardiology Conferences
Electrocardiography uses electrodes mounted on the skin over a period of time to monitor the heart's electrical activity. To identify any cardiac problems, this procedure is used.
ECG is used to obtain the heart's structure and function. Some indications for performing an ECG include: • Cardiac attack or chest pain • ST elevated myocardial infarction • Suspected pulmonary embolism • Cardiac whispering• Monitoring of known cardiac arrhythmias • Fainting• Seizures• Monitoring of cardiac effects• Hypertrophic cardiomyopathy • Cardiac stress testing • Computed tomography • Patient biotelemetry
Holter (Ambulatory) monitoring | Event/loop recording | Cardiopulmonary exercise test (CPET)| Signal-averaged electrocardiogram | Heart rate monitor | Pacemaker monitoring| Electric axis of the heart | Medical therapies and procedures | Cardiac surgery and hybrid procedures | Transthoracic echocardiography
Electrocardiograph The market was valued at $5.1 billion in 2020, and is expected to increase at a CAGR of 5.8% from 2021 to 2026. An electrocardiograph is a non-invasive test for checking and recording heart electrical activity.
Stroke Conferences Robotic Cardiac Surgery Conferences Heart Conferences Vascular Biology Conferences Heart Congress Japan Sports Cardiology Conferences Cardiology Conferences 2022 USA Acute Coronary Syndromes Conferences Cardio-Oncology Conferences Cardiovascular Pharmacology Conferences Pulmonology Conferences Peers Alley Media Conferences Valvular Heart Disease Conferences Cardiology Conferences 2022 Asia Cardiology Conferences 2022
Throughout cancer treatment, it is an interdisciplinary area of medicine that deals with clinical and molecular changes in the cardiovascular system, particularly chemotherapy and radiation therapy.
Patients with cardiac tumors usually experience infinite symptoms such as dyspnea, fatigue, thoracoabdominal pain, nausea, fever, hemoptysis, diarrhea, and weight loss.
The diagnosis is mostly based on clinical history; the patient has been diagnosed with cardiac tumors for the first time after a stroke, an embolism caused by weakened tumor tissue.
Advanced cancer therapy | Heart malignancy | Intra-cardiac tumor | Cardiomyopathy | HER2-directed therapy | Vascular toxicities | Chemotherapy-related cardiac dysfunctions | Cardio-oncology programs
Stroke Conferences Peers Alley Media Conferences Myocardial Infarction Conferences Cardiovascular Pharmacology Conferences Cardiac Imaging Conferences Heart Conferences Thrombosis Conferences Heart Congress Japan Cardiology Conferences 2022 Asia Pulmonology Conferences Peers Alley Media Conferences Cardiology Conferences 2022 Australia Geriatric Cardiology Conferences Robotic Cardiac Surgery Conferences Cardiac Nursing Conferences
Interventional cardiology is a cardiology sub-specialty that deals specifically with systemic heart disease treatment based on the catheter.
A large number of operations can be performed on the heart via catheterization.
Specific treatments for interventional cardiology include angioplasty, percutaneous coronary operation, valvuloplasty, congenital heart defect reversal, percutaneous valve replacement, percutaneous valve repair, and coronary thrombectomy. The main benefits of using cardiology or radiology intervention approaches are the avoidance of wounds, pain, and lengthy post-operative recovery.
Interventional cardiologists in the U.S. and Canada require a minimum of seven years of postgraduate medical education and those who wish to specialize in multiple structural cardiac procedures need up to nine years of postgraduate medical education.
Cardiac catheterization | Angioplasty | Coronary stents | Embolic protection | Percutaneous valve repair | Balloon valvuloplasty| Atherectomy
Due to COVID-19, the worldwide interventional cardiology market size is expected to be roughly $11.1 billion in 2020, down from over $14 billion in 2019. The global market is predicted to reach an astounding $16.2 billion in 2027.
Boston Scientific, Abbott, and Medtronic collectively held more than 40% of the global interventional cardiology market share.
As a result of COVID19, the worldwide interventional cardiology market size declined by 20% from 2019 to 2020, reaching a valuation of $11.1 billion in 2020.
Valvular Heart Disease Conferences Cardiology Conferences 2022 Dyslipidemia Conferences Heart Diseases in Woman Conferences Peers Alley Media Conferences Cardiology Conferences 2022 Canada Cardiology Case Reports Conferences Heart Congress Japan Clinical Cardiology Conferences Interventional Cardiology Conferences Cardiologist Conferences Cardiac Imaging Conferences Cardiology Conferences 2022 Asia Peers Alley Media Conferences Thrombosis Conferences
Nuclear cardiology is a cardiology sub-specialty that conducts a wide variety of non-invasive cardiovascular imaging studies, including: myocardial perfusion imaging (nuclear stress testing) to diagnose and control coronary artery disease, radionuclide cineangiograms, and viability studies to determine the severity of myocardial infarction and to evaluate heart function.
Were studies in nuclear cardiology used to evaluate?
• Your heart function • Blood flow to the heart muscle • Lifestyle interventions and medicines • Best possible heart treatments• Whether shortness of breath, chest discomfort or fatigue is caused by heart disease.
A widest range of tests performed under Nuclear Cardiology are • Myocardial perfusion tests • Ventricular function studies • PET scans • Resting myocardial perfusion scan • MUGA scans
Modern practices in cardiovascular therapy | Vasodilators | Percutaneous Coronary Intervention (PCI) | Heart Transplant| Application of cardiac progenitor cells | Imaging| Computed Tomography | Cardiac Magnetic Resonance | Nuclear Imaging | Molecular Imaging | Nuclear Cardiology | Hybrid and Fusion Imaging | Cross-Modality and Multi-Modality Imaging Topics
The nuclear medicine market is expected to grow at a 9.0 percent compound annual growth rate (CAGR) from USD 4.8 billion in 2021 to USD 7.5 billion in 2026.
This market is divided into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. In terms of the nuclear cardiology market, North America has remained ahead of the other regions due to its superior capacity to handle new and highly advanced technologies.
Furthermore, new low-cost technologies like PET and PACS imaging technology will drive up demand for nuclear cardiology devices.
Vascular Biology Conferences Cardiac Imaging Conferences Peers Alley Media Conferences Acute Coronary Syndromes Conferences Cardiologist Conferences Heart Conferences Cardiovascular Pharmacology Conferences Cardiology Conferences 2022 Asia Valvular Heart Disease Conferences Atherosclerosis Conferences Cardiology Conferences 2022 Japan Electrocardiography Conferences Heart Diseases in Woman Conferences Clinical Cardiology Conferences Pediatric Cardiology Conferences
Cardiac nursing is a sub-specialty of nursing for patients suffering from different conditions and complications of the cardiovascular system. Heart nurses perform various tasks such as stress test tests, artery testing, heart monitoring, surgical unit postoperative treatment, and safety evaluations.
Cardiac nurses work in a variety of environments including coronary care units (CCU), intensive care units (ICU), cardiac catheterization, operating theatres, clinical research, cardiac rehabilitation centres, cardiovascular intensive care units, cardiac surgery wards and surgical wards.
Cardiac nurses are registered nurses who, under the supervision of a cardiologist, help treat numerous patient conditions such as unstable angina, coronary artery disease, cardiomyopathy, myocardial infarction, congestive heart failure and cardiac dysrhythmia.
Cardiac Diseases| Cardiac Surgery| Cardiac Nursing| Heart Diagnosis| Hypertension and Obesity| Stroke| Coronary artery disease| Cardiologists| Heart Regeneration| Angiography| Interventional Cardiology| Clinical Cardiology & Diabetes| Nursing Care| Cardiac Pharmacology| Case Reports on Cardiology| Clinical cardiac electrophysiology| Pediatric cardiology| Cardiac Research| Advanced Nursing
Salary for cardiovascular nurses varies depending on experience, region, and education level. These individuals earn an average base income of $88,646 each year. Total pay for cardiovascular nursing salary ranges from $51,000 to $90,000.
In general, the job prognosis for nurses is also positive. According to the Bureau of Labor Statistics, the number of registered nurses will increase by 7% between 2019 and 2029. With the ageing of the Baby Boomer generation and the prevalence of heart disease in the United States, the need for cardiovascular nurse employment is expected to rise.
Overall, the Bureau of Labor Statistics predicts that the registered nurse profession will grow by 7% between 2019 and 2029, which is good news for nurses of all specialties. Cardiovascular health is likewise a high-demand component of the healthcare system. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, accounting for one out of every four deaths. In other words, there is still a demand for cardiovascular nursing employment in the sector.
Sports Cardiology Conferences Cardiology Conferences 2022 Cardiology Conferences 2022 USA Cardiovascular Pharmacology Conferences Interventional Cardiology Conferences Cardiology Case Reports Conferences Vascular Biology Conferences Cardiology Conferences 2022 Europe Heart Conferences Cardiology Conferences 2022 Canada Electrocardiography Conferences Nuclear Cardiology Conferences Clinical Cardiology Conferences Heart Congress Japan Thrombosis Conferences
For rising and evolving people, pediatric cardiology is a sub-specialty in pediatrics concerned with heart disease.
Pediatric cardiologists are physicians who diagnose and treat children with heart disease, including • congenital heart disease• infant cardiovascular collapse • infant and child cardiac insufficiency • neonatal cyanosis • children with heart murmur • artery transposition • children and adolescents with chest pain• cardiovascular disorders• fetal heart murmur • artery transposition • children and adolescents with chest pain • cardiac defects•
• Management of critically ill children with heart problems Different procedures and procedures include: • Electrocardiogram (ECG) • Advanced imaging – CT / MRI • chest x-ray • exercise testing • pediatric cardiac transplantation • cardiac event recording • balloon atrial septostomy • cardiac ultrasound scans.
All pediatric cardiologists must complete specialized training in one of the following areas: • advanced imaging (CT / MRI) • advanced echocardiography • adult congenital heart disease • fetal cardiology • therapeutic catheterization • invasive electrophysiology • pulmonary hypotension • heart failure and cardiac transplantation
Pediatrics| Clinical Pediatrics| Pediatric Cardiology| Pediatric Congenital Heart Disease| Pediatric Heart Murmurs| Cardiac Stroke| Fetal Cardiology| Pediatric Cardiac Tumors| Pediatric Kawasaki Disease| Pediatric Atherosclerosis| Tetralogy Of Fallot In Infants| Pediatric Pericarditis| Rheumatic heart disease| Pediatric Aortic Stenosis| Pediatric Pulmonary Atresia| Cardiac nursing| Pediatric Nursing
The worldwide paediatric interventional cardiology market is divided into two parts: device type and geography. The market is further divided into congenital heart defect closure devices, transcatheter heart valves, and others based on the kind of device (catheters, guidewires, balloons, and stents).
Interventional cardiology is a subspecialty of cardiology that treats coronary artery, valvular, and congenital heart disorders with intravascular catheter-based procedures and fluoroscopy. Pediatric interventional cardiology is the practise of performing interventional cardiology on newborns, children, and adolescents up to the age of 18.
St. Jude Medical (U.S.), Boston Scientific (U.S.), Gore Medical (U.S.), Abbott Vascular (U.S.), GE Healthcare (U.S.), Edward LifeSciences (U.S.) and Siemens Healthcare are among the market's major players (Germany).
Cardiology Conferences 2022 Japan Cardiac Nursing Conferences Arrhythmia Conferences Cardiac Regeneration Conferences Cardiology Case Reports Conferences Hypertension Conferences Cardiology Conferences 2022 Cardiology Conferences 2022 USA Peers Alley Media Conferences Myocardial Infarction Conferences Cardiology Conferences 2022 Canada Pulmonology Conferences Cardio-Oncology Conferences Electrocardiography Conferences Acute Coronary Syndromes Conferences
A stroke is a medical condition that results in cell death due to decreased blood flow to the brain.
There are two main types of stroke: ischemic: due to lack of blood flow Hemorrhagic: due to bleeding Signs and symptoms of a stroke: it may cause dizziness, difficulties in understanding or communicating, loss of vision and inability to move or respond on one side of the body, pneumonia and loss of bladder control. Stroke symptoms can last for a long time.
Risk factors for Stroke include high blood pressure, high blood cholesterol, smoking tobacco, obesity, previous TIA, diabetes mellitus, blockage of a blood vessel, and atrial fibrillation.
Diagnosis and prevention: Diagnosis is usually based on a physical examination and is accompanied by medical imaging such as MRI or CT scanning, electrocardiogram (ECG) and blood testing to assess risk factors.
Prevention involves the elimination of risk factors, as well as the use of statins, aspirin, surgery to open up artery defect narrowing, and warfarin in those with atrial fibrillation.
Stroke is a leading cause of disability in the U.S. and has declined from the third to fourth leading cause of death recently. 95% of strokes occur in people over 45 years of age and 2/3 of strokes occur in people over 65 years of age.
Between 1990 and 2010, the number of strokes in the developing world increased by 10 percent and in the developed world dropped by 10 percent. Overall, 2/3 of the strokes registered in those over 65 years of age. South Asians are disproportionately high at risk of stroke, contributing 40% of deaths from strokes worldwide. Among women, 60% of stroke deaths occur, but men are 25% more likely than women to suffer from stroke.
Assessment of Stroke Patients | Stroke Etiology | Acute Stroke Imaging | Management of Stroke Patients | Stroke in Consultation | Prevention of First and Recurrent Stroke
The Global Stroke Management Market was worth $22,581 million in 2016 and is expected to be worth $36,756 million by 2023, expanding at a CAGR of 7.1 percent during the study period (2017-2023). Stroke is a medical emergency that occurs when blood flow to the brain is disrupted, causing brain cells to die.
The Stroke Management Market's Key Findings:
• The diagnostics sector dominated the market in 2016 and is expected to grow at the fastest CAGR of 8.1 percent in 2017.
• In 2016, the ischemic stroke category accounted for the largest share.
• In 2016, the United States was the largest shareholder in the North American stroke management market.
• During the analysis period, Asia-Pacific is predicted to have the highest growth rate.
• In the Asia-Pacific market, China is predicted to develop at the fastest CAGR.
Clinical Cardiology Conferences Cardiac Regeneration Conferences Vascular Biology Conferences Cardiology Conferences 2022 Asia Hypertension Conferences Arrhythmia Conferences Nuclear Cardiology Conferences Robotic Cardiac Surgery Conferences Cardiology Case Reports Conferences Peers Alley Media Conferences Geriatric Cardiology Conferences Sports Cardiology Conferences Heart Diseases Conferences Valvular Heart Disease Conferences Cardiology Conferences 2022 Europe
Cardiac surgeons are the doctors who conduct heart surgery or blood arteries to repair damage caused by cardiovascular system diseases. Complications such as ischemic heart disease, heart transplants, congenital heart disease, valvular heart disease including endocarditis, atherosclerosis, and rheumatic heart disease were treated.
Cardiac surgeons usually do:• Treat heart failure and heart disease • Repair or replace heart valves • Repair damaged or abnormal heart structures • Implant medical devices that support blood flow, heart beat and heart function • Control of abnormal heart rhythms.
Various types of heart surgery • Aortic surgery • Aortic ventricular surgery • Congenital heart surgery • Coronary artery bypass graft surgery • heart transplantation • Left ventricular surgery • Right ventricular surgery • Surgical ventricular repair • Myectomy / myotomy • Valvular surgery
Perioperative Management | Surgery for ischemic Heart Disease | Surgery for Valvular Heart Disease | Surgery for Heart Failure | Thoracic Aortic Disease | Surgery for Cardiac Rhythm Disorders and Tumors | Surgery for Congenital Heart Disease
The global market for cardiac surgical instruments is predicted to reach USD 1.63 billion by 2022, up from USD 1.16 billion in 2017, at a CAGR of 7.1%.
Europe dominated the global market in 2017, followed by North America. The European market is primarily driven by increased use of surgical treatments in cardiology, expansion in the European healthcare sector, and public awareness campaigns. The Asian market, on the other hand, is expected to grow at the fastest CAGR due to increased government and private sector spending in healthcare, rising purchasing power, and a high prevalence of cardiac disorders. China, India, and Japan are three of Asia's most important marketplaces.
Heart Congress Japan Electrocardiography Conferences Thrombosis Conferences Cardiology Conferences Cardiac Surgery Conferences Vascular Biology Conferences Clinical Cardiology Conferences Arrhythmia Conferences Cardiology Conferences 2022 Robotic Cardiac Surgery Conferences Sports Cardiology Conferences Pediatric Cardiology Conferences Cardiology Case Reports Conferences Cardiovascular Pharmacology Conferences Cardiology Conferences 2022 Asia
Thrombosis is the development of a blood clot within a blood vessel that prevents blood flow through the circulatory system. When a blood vessel is broken, the body releases platelets and fibrin to form a blood clot and prevent blood loss.
In veins or arteries, thrombosis can occur.
Venous thrombosis: leads to blockage of the affected part of the body Arterial thrombosis: it affects the blood supply and allows the artery to cause tissue damage.
Specific thrombosis forms depending on the affected vessel type 1. Venous thrombosis • Cerebral venous sinus thrombosis• Deep vein thrombosis• Budd-Chiari syndrome• Cerebral venous sinus thrombosis • Cavernous sinus thrombosis 2. Thrombosis of the heart• Stroke• Myocardial infarction 3. Limb ischemia Prevention: if there are no problems with bleeding, the use of heparin following surgery is standard preventive treatment.
Prevention: There are multiple thrombosis prevention approaches, including· Anticoagulation· Thrombolysis· Surgery· Endovascular therapy· Endovascular therapy
Hemostasis and Thrombosis | Coagulation and Its Regulation | Fibrinolysis and Its Regulation | Platelet Structure and Function | Thrombohemorrhagic Disorders | Therapy, New Directions and Complications in Thrombohemorrhagic Disorders
Acute Coronary Syndromes
Coronary arteries are the part of heart muscles, in which the blood flow decreases due to acute coronary syndromes results in failed to function properly. Most common symptoms associated with ACS are chest pain, nausea, sweating and diabetes mellitus in older patients.
ACS is most commonly connected with three clinical manifestations: These types are names as per the appearance of Electrocardiogram (ECG). 1. ST elevation myocardial infarction (STEMI, 30%), 2. Non ST elevation myocardial infarction (NSTEMI, 25%) 3. Unstable angina (38%)
Different diagnosis methods
• Imaging and blood tests
• Prediction scores
Acute coronary syndrome often reflects a degree of damage to the coronaries by atherosclerosis. Primary prevention of atherosclerosis is controlling the risk factors: healthy eating, exercise, treatment for hypertension and diabetes, avoiding smoking and controlling cholesterol levels; in patients with significant risk factors, aspirin has been shown to reduce the risk of cardiovascular events. Secondary prevention is discussed in myocardial infarction.
After a ban on smoking in all enclosed public places was introduced in Scotland in March 2006, there was a 17% reduction in hospital admissions for acute coronary syndrome. 67% of the decrease occurred in non-smokers.
People with presumed ACS are typically treated with aspirin, clopidogrel or ticagrelor, nitroglycerin, and if the chest discomfort persists morphine
Reduction of Atherothrombosis for Continued Heath | Pathogenesis: Acute Coronary Syndrome | Molecular Mechanisms: Acute Coronary Syndrome | Immune System in Acute Coronary Syndrome | Myocardial Cell Death and Regeneration | Pharmacogenomics | Acute Ischemic Heart Disease | Echocardiography in Acute Coronary Syndrome | Nuclear Cardiology Techniques in Acute Coronary Syndrome | Plaque Passivation and Endothelial Therapy | The Modern Cardiac Unit | Antiplatelet Therapy | Anticoagulants
Cardiology Conferences 2022 Australia Pulmonology Conferences Cardiology Conferences 2022 Japan Cardiology Conferences 2022 Asia Vascular Biology Conferences Cardiac Regeneration Conferences Interventional Cardiology Conferences Cardiology Case Reports Conferences Cardiology Conferences 2022 Canada Clinical Cardiology Conferences Electrocardiography Conferences Atherosclerosis Conferences Myocardial Infarction Conferences Cardiac Imaging Conferences Cardiology Conferences 2022
Heart arrhythmia is a set of conditions where the heartbeat is irregular, too slow, or too fast. Bradycardia: A heart rate below 60 Tachycardia beats per minute: a heart rate in adult symptoms above 100 beats per minute: Arrhythmia typically has no symptoms. Yet some symptoms usually found in Arrhythmia patients, such as lightheadedness, palpitations, or feeling a pause between heartbeats, shortness of breath, passing out, or chest pain.
Four major types of arrhythmias exist:· Extra beats· Supraventricular tachycardia· Ventricular arrhythmias· Bradyarrhythmias
Diagnosis: The Electrocardiogram (ECG) and Holter monitor are different tests and procedures that can aid in the diagnosis of arrhythmia.
Treatment: It is possible to treat most arrhythmias effectively. Treatments may include medicines such as beta blockers, surgery, different medical procedures such as installing a pacemaker or procainamide agents to restore normal heart rhythm. Many forms of cases of arrhythmia lead to sudden death or heart arrest.
Arrhythmia is affecting millions. Around 80% of sudden cardiac death is the result of ventricular arrhythmias. Approximately 15% of all sudden cardiac deaths are caused by global cardiovascular disease.
Atrial fibrillation affects about 2% to 3% of the population in Europe and North America as of 2014.
Sinus node: Normal and Abnormal Rhythms | Bradyarrhythmias | Ectopic Complexes and Rhythms | Tachycardia | Supraventricular Tachyarrhythmias | Ventricular Tachyarrhythmias | Cardiac Pacing and Pacemaker Rhythms | Implantable Cardioverter Defibrillators | Athletes and Arrhythmias | Drug Effects and Electrolyte Disorders | Treatment of Arrhythmias | Management of Arrhythmias in Pregnancy
Cardiology Conferences 2022 USA Interventional Cardiology Conferences Cardiology Conferences Hypertension Conferences Cardiovascular Pharmacology Conferences Acute Coronary Syndromes Conferences Stroke Conferences Electrocardiography Conferences Cardiac Regeneration Conferences Peers Alley Media Conferences Heart Conferences Cardiology Conferences 2022 Australia Cardiac Nursing Conferences Cardiology Conferences 2022 Robotic Cardiac Surgery Conferences
Valvular heart failure is any disorder that affects one or more of the heart's four valves. Such disorders are caused by age, congenital (inborn) defects, pregnancy, and heart disease from rheumatism.
Treatment: Some of the most common treatments for valvular heart disease are briefly offered as: • Avoid excessive alcohol consumption • Do not smoke• Antibiotic drugs • Anti-Thrombotic drugs such as aspirin • Anticoagulant such as warfarin • Balloon dilatation • Medication for water pills
Epidemiology of Valvular Heart Disease | Cellular and Molecular Basis of Calcific Aortic Valve Disease | Clinical and Genetic Risk Factors for Calcific Valve Disease | Evaluation of Valvular Heart Disease by Cardiac Magnetic Resonance and Computed Tomography | Aortic Stenosis | Aortic Regurgitation | Aortic Valve Implantation | Surgical Approach to Diseases of the Aortic Valve | Rheumatic Mitral Valve | Myxomatous Mitral Valve | Infective Endocarditis | Prosthetic Heart Valves | Valvular Heart Disease in Pregnancy
Clinical Cardiology Conferences Robotic Cardiac Surgery Conferences Heart Conferences Nuclear Cardiology Conferences Cardiology Conferences 2022 Europe Arrhythmia Conferences Acute Coronary Syndromes Conferences Cardiac Nursing Conferences Sports Cardiology Conferences Cardiac Imaging Conferences Pulmonology Conferences Cardiology Conferences 2022 Japan Myocardial Infarction Conferences Interventional Cardiology Conferences Cardiology Conferences 2022 Asia
Cardiology is a branch of medicine that focuses on cardiovascular disease research, diagnosis and treatment. Cardiovascular diseases include heart disease, high blood pressure, arrhythmia, or stroke.
Pulmonology is a medical specialty dealing with diseases of the respiratory tract. Pulmonologists are trained in chest diseases, mainly pneumonia, asthma, emphysema, tuberculosis, and complicated infections of the chest.
Allergic bronchopulmonary aspergillosis | Asthma | Chronic obstructive pulmonary disease | Chronic bronchitis | Emphysema | Cystic fibrosis | Lung canceriagnosis | Pneumoconiosis | Pneumonia | Pneumothorax | Psittacosis | Pulmonary embolism | Pulmonary fibrosis | Pulmonary hypertension | Pulmonary sequestration | Sarcoidosis | Sleep apnea | Tuberculosis | Internal medicine | Intensive care medicine.
Cardiology Conferences 2022 Europe Cardiology Conferences Interventional Cardiology Conferences Cardiac Nursing Conferences Acute Coronary Syndromes Conferences Geriatric Cardiology Conferences Heart Congress Japan Cardiology Case Reports Conferences Cardio-Oncology Conferences Pediatric Cardiology Conferences Peers Alley Media Conferences Heart Conferences Cardiac Regeneration Conferences Cardiology Conferences 2022 Canada Heart Diseases Conferences
Atherosclerosis is a condition that prevents the supply of oxygen-rich blood to parts of the body due to the accumulation of plaque.
Atherosclerosis is caused by abnormal levels of cholesterol, diabetes, obesity, high blood pressure, smoking, inherited, and unhealthy diet.
In the initial stage, no symptoms appear until serious, depending on which arteries are affected, it can lead to stroke, coronary artery disease, kidney problems and peripheral artery disease.
Atherosclerosis usually occurs in men in the 40s and women in the 50s to 60s.According to data from 2004, the first symptom of atherosclerotic cardiovascular disease results in heart attack or sudden cardiac death in about 66 percent of men and 47 percent of women in the United States.
Prevention: Usually by taking a healthy diet, not smoking, exercising, and keeping a normal weight.
Treatment: involves medicines for blood pressure, medicines for lowering cholesterol such as statins, or medications for reducing coagulation, such as aspirin. Also, various procedures such as coronary artery bypass grafting, percutaneous coronary intervention, or carotid endarterectomy can be performed.
Pathogenesis of Atherosclerosis | Chemokines and Atherosclerosis: A critical Assessment of Therapeutic Targets | Adhesion Molecules and Atherosclerosis | Cytokines and Atherosclerosis | Toll-Like Receptors in Atherosclerosis| PPAR-Based Therapies for the Management of Atherosclerosis | Pentraxins in Vascular Pathology | Metalloproteinase, the Endothelium and Atherosclerosis | Cathepsins in Atherosclerosis | The Plasmin system and Atherosclerosis | Mast Cell Proteases and Atherosclerosis | NADPH Oxidase and Atherosclerosis | Hene Oxygenase-1 and Atherosclerosis | Platelets: Role in Atherogenesis and thrombosis in Coronary Artery Disease
Sports Cardiology Conferences Heart Conferences Cardiology Conferences 2022 Heart Diseases Conferences Acute Coronary Syndromes Conferences Cardiology Conferences Cardiac Nursing Conferences Hypertension Conferences Interventional Cardiology Conferences Electrocardiography Conferences Dyslipidemia Conferences Clinical Cardiology Conferences Cardiac Surgery Conferences Valvular Heart Disease Conferences Robotic Cardiac Surgery Conferences
Sports cardiology is a cardiology sub-specialty where cardiologists, exercise physiologists, physicians, physical therapists, nurses, nutritionists, coaches, and psychologists are diagnosing and treating cardiac conditions in order to keep athletes healthy and competitive in sports.
To assess and treat symptoms, doctors work closely with individuals. We conduct• A thorough review of medical history• A thorough review of sporting history • Examine all heart problems and symptoms• Cardiovascular physical examination • Electrocardiogram • Laboratory testing • Cardiopulmonary exercise monitoring • Assessment and assessment in sports medicine • Physical therapy• Suggestion to remain active in sports • Training to improve efficiency in athletics
Athlete's Heart | Electrocardiography in athletes | Radionuclide Scintigraphy in athletes | Athlete's bradycardia | Exercise in healthy subjects| Exercise in cardiovascular disease | Sports and Hypertension| Exercise and sports in congenital heart disease | Sports and cardiovascular disease | Sudden cardiac death in sports | Accurate diagnosis and treatment plans | Frequency and causes of SCA in young athletes | Cardiovascular assessment
Sports Cardiology Conferences Cardiovascular Pharmacology Conferences Peers Alley Media Conferences Acute Coronary Syndromes Conferences Cardiology Conferences 2022 Europe Interventional Cardiology Conferences Pediatric Cardiology Conferences Geriatric Cardiology Conferences Cardiac Regeneration Conferences Arrhythmia Conferences Peers Alley Media Conferences Cardiology Conferences 2022 Asia Thrombosis Conferences Cardiologist Conferences Heart Conferences
Cardiac imaging is a diagnostic radiology subspecialty in which cardiac radiologist conducts and then interprets medical images to diagnose heart disease, heart failure, heart failure, heart failure and heart shape, and leaky heart valves.
Cardiac (heart) imaging techniques include:· Coronary catheterization· Echocardiogram· Intravascular ultrasound· Cardiac PET scan· Cardiac CT scan· Cardiac MRI· X-rays These scans are used to diagnose cardiac signs, control the heart, assess and track heart failure and clinical congenital heart disease management.
Ischemic Heart Disease| Heart Failure| Acquired Valvular Heart Diseases| Cardiomyopthy | Cadiovascular Computed Tomography| Cadiovascular Magnetic Resonance| Great Vessel Abnormalities| Congenital Heart Disease| Coronary Artery Variant and Anomalies| Coronary Artery Disease| Myocardial Disease-Ischemia and Infraction| Myocardial Disease- Cardiomyopathy| Myocardial Disease- Masses| Cardiac Valvular Disease| Pericardial Disease| Postintervention/Postoperative
The global market for Heart Imaging, which was valued at US$14.8 billion in 2020, is expected to reach a revised size of US$27.5 billion by 2027, rising at a CAGR of 9.3% between 2020 and 2027.
The market for structural heart imaging in the United States is expected to be worth $4 billion by 2020. China, the world's second largest economy, is expected to reach a projected market size of US$5.8 billion by 2027, with a CAGR of 12.3% from 2020 to 2027. Other notable geographic markets include Japan and Canada, which are expected to increase at 6.3% and 7.9%, respectively, between 2020 and 2027. Germany is expected to expand at a CAGR of about 7.2% in Europe.
Asia-Pacific is expected to reach US$3.9 billion by 2027, led by countries such as Australia, India, and South Korea, while Latin America will grow at a 9.4% CAGR during the analysis period.
Heart Conferences Cardiology Conferences 2022 Thrombosis Conferences Cardiac Regeneration Conferences Acute Coronary Syndromes Conferences Sports Cardiology Conferences Cardiology Conferences 2022 USA Cardiology Conferences 2022 Australia Pulmonology Conferences Heart Diseases Conferences Cardiologist Conferences Cardiac Imaging Conferences Pediatric Cardiology Conferences Nuclear Cardiology Conferences Cardiology Conferences 2022 Asia
The vascular system consists of small and large vessels specifically designed to have different levels of blood flow and pressure depending on the body's location.
Vascular tissue consists of a different cell type population, including endothelial cells, pericytes, fibroblasts, smooth muscle cells, and other types of connective tissue cells. The amalgamation of these types of cells constitutes the vascular tissue and forms connections that allow active and passive transportation across the wall of the vessel.
Endothelial cells in the vascular tissue are also involved in a number of other tasks, including: supplying an inner layer to the heart and blood vessels · Discharge of bioactive molecules to affect local cell settings · Influence of normal microvascular growth and angiogenesis · Transfer of molecules from the blood to interstitial fluid · Contiguous smooth muscle relationship.
Physiology of Blood vessels | Immunology of the vessel wall | Biology of thee vasculature | The endothelial cell | Vascular smooth muscle cells | Arteriogenesis Vs Angiogenesis | The lymphatic system | Pathogenesis of atherosclerosis | Atherosclerosis | Molecular Mechanisms | Pathophysiology of other cardiovascular diseases | Valvular heart diseases | Pathophysiology of thrombosis | Vascular pathophysiology of hypertension
The global vascular grafts market was worth USD 1.6 billion in 2020, and it is predicted to increase at a CAGR of 6.8% between 2021 and 2028. The rising prevalence of cardiovascular illnesses, diabetes, and end-stage renal disease are all propelling the market. According to the American Heart Association, an estimated 121.5 million people in the United States suffer from cardiovascular disorders such as high blood pressure, chest pain, heart attack, and stroke.
Valvular Heart Disease Conferences Peers Alley Media Conferences Heart Congress Japan Cardiology Case Reports Conferences Cardiologist Conferences Pediatric Cardiology Conferences Cardiology Conferences 2022 Asia Heart Conferences Heart Diseases Conferences Clinical Cardiology Conferences Cardiology Conferences 2022 Canada Cardio-Oncology Conferences Cardiology Conferences 2022 USA Arrhythmia Conferences Hypertension Conferences
A case report in medicine is a comprehensive report of an individual patient's signs, symptoms, diagnosis, treatment, management and follow-up. For science, medical and educational purposes, case reports can be circulated.
For medical-clinical research, evidence-based medicine, a case report plays a vital role and offers a case-based learning framework.
Case studies on cardiology are intended for: • Learning about medical cases or patients with heart problems offers valuable experience for cardiologists, physicians and paramedic personnel • Learning different diagnostic procedures from various medical cases• Positive and negative results, demographic profile of patients, tests and inquiries, including clinical photos, should be included in the case report.
Case Reports on Heart Disease & Failure | Case Reports on Vascular Heart Disease | Case Reports on Myocardial and Pericardial Disease | Case Reports on Pediatric Cardiology | Case Reports on Arrhythmias | Case Reports on Atherosclerosis | Case Reports on Hypertension and Healthcare | Case Reports on Heart Regeneration | Case Reports on Cardiac and Cardiovascular Research | Case Reports on Heart Diagnosis | Case Reports on Heart Devices | Case Reports on Cardiac Surgery | Case Reports on Cardiology - Future Medicine
Robotic Cardiac Surgery Conferences Cardiology Conferences 2022 Asia Cardiology Conferences 2022 Cardiology Conferences 2022 USA Cardiologist Conferences Cardiology Conferences 2022 Canada Cardiology Conferences 2022 Australia Cardiovascular Pharmacology Conferences Heart Diseases in Woman Conferences Peers Alley Media Conferences Heart Diseases Conferences Myocardial Infarction Conferences Acute Coronary Syndromes Conferences Cardiac Regeneration Conferences Arrhythmia Conferences
Geriatric cardiology is a subdiscipline of cardiology and geriatric medicine dealing with cardiovascular disorders in the elderly.
In addition to vascular disorders such as atherosclerosis, peripheral arterial disease, cardiac disorders such as heart failure, myocardial infarction, arrhythmias, cardiomyopathy are the cause of morbidity and mortality in the elderly.
Cardiology | Geriatrics | Elderly care | Heart diseases | Atherosclerosis | Peripheral arterial disease
In 2015, the global geriatric medication market was worth roughly USD 540 billion. The fast growing geriatric population base is one of the primary elements contributing to its rapid expansion. The worldwide geriatric population was estimated to be approximately 809.4 million in 2012, according to UN estimations, and is expected to reach almost 1.13 billion by 2022, and exceed a value of over 2 billion by 2050.
The growing elderly population in the world, as well as the increasing incidence of cardiovascular illnesses, are two of the most important aspects driving market revenue growth.
A new report from Emergen Research estimates that the global interventional cardiology devices market had a value of USD 13.72 billion in 2020 and is predicted to grow to USD 26.84 billion in 2028, with a revenue compound annual growth rate of 8.7 percent over the forecast period of 2021-2028.
Heart Diseases Conferences Cardiac Surgery Conferences Sports Cardiology Conferences Dyslipidemia Conferences Cardiology Conferences 2022 Europe Vascular Biology Conferences Cardiac Regeneration Conferences Cardiovascular Pharmacology Conferences Myocardial Infarction Conferences Nuclear Cardiology Conferences Heart Diseases in Woman Conferences Cardiology Conferences Heart Congress Japan Electrocardiography Conferences Interventional Cardiology Conferences
Cardiovascular pharmacology focuses primarily on medications used in cardiovascular disease treatment, both existing and emerging groups of drugs.
The Cardiovascular Physiology and Pharmacology of Endothelin-I | Vascular Pharmacology of Epoxyeicosatrienoic Acids | Prostaglandins in Action | TP Receptors and Oxidative Stress | Regulation of Endothelial Cell Tetrahydrobiopterin | Polyphenol-Induced Endothelium-Dependent Relaxations | Organic Nitrates and Nitrate Tolerance | Vascular Actions of Adipokines | Cardiovascular Effects of Erythropoietin
By 2022, the global cardiovascular medicines market is expected to have grown from $141.1 billion in 2017 to $149.4 billion, representing a compound annual growth rate (CAGR) of 1.2 percent between 2017 and 2022.
Cardiovascular illnesses are one of the most common causes of death throughout the world. Following the American Heart Association's estimates, around 41.5 percent of the United States' population was suffering from some type of cardiovascular disease in 2015. This prevalence is expected to rise to 45 percent by 2035, according to the American Heart Association. Patients suffering from cardiovascular diseases are projected to increase in number as a result of a more sedentary lifestyle, shifting food habits, and an increase in risk factors.
Thrombosis Conferences Cardiology Conferences 2022 Australia Cardio-Oncology Conferences Interventional Cardiology Conferences Nuclear Cardiology Conferences Stroke Conferences Valvular Heart Disease Conferences Cardiovascular Pharmacology Conferences Cardiology Conferences 2022 Asia Hypertension Conferences Sports Cardiology Conferences Cardiology Conferences 2022 Europe Pediatric Cardiology Conferences Acute Coronary Syndromes Conferences Cardiac Regeneration Conferences
Robotic surgery is often referred to as surgery with da Vinci. Robotic surgery is a heart surgery in which surgeons conduct heart surgery using small tools and robot-controlled devices.
Robotic surgery has several uses, including coronary artery bypass, valve surgery, heart defect repair, cardiac ablation, and tumor removal, in various heart-related procedures.
Robotic surgery benefits • Removal of tumors in the heart • Treatment of congenital heart conditions • Repair or replacement of leaky or rigid heart valves• Correct atrial fibrillation, a common type of arrhythmia • Minimally invasive treatment compared to open-heart surgery• Rapid healing.
• Less ricks compared to open-heart surgery• Less damage to the patient, including less discomfort • Shorter hospital stay (usually 3 to 4 days)• Diminished use of pain medications• Less bleeding • Diminished risk of infection Risks of robotic surgery The patient will undergo a series of pre-robotic surgery procedures during which the patient's age, medical history, gender, and environment should be treated.
Robotic cardiac surgery often entails risks, including:· Heart attack· Stroke· Infection· Death
Anesthesia for Robotic Cardiac Surgery | Robotic Mitral Valve Surgery | Robotic Coronary Bypass Graft on Beating Heart | Robotic Surgery in Congenital Heart Disease | Intraoperative Transesophageal Echocardiography | Hybrid coronary revascularization | Robotic Left Ventricular Epicardial Lead Implantation
The need for heart surgery is increasing over the world. During the period 2017-2025, robots will have a cumulative market value of $7.50 billion, owing to the large increase in the number of robot-based and computer-assisted cardiological surgery procedures for the treatment of heart problems.
According to industry estimates, the global surgical robots market is estimated to reach USD 6.4 billion in 2021 and to increase at a compound annual growth rate (CAGR) of 17.6 percent from 2021 to 2026. Surgical robots allow surgeons to perform complex surgical procedures with greater precision.
Cardiology Conferences 2022 Canada Dyslipidemia Conferences Cardiology Conferences 2022 Japan Cardiac Surgery Conferences Hypertension Conferences Cardiology Conferences 2022 USA Nuclear Cardiology Conferences Cardio-Oncology Conferences Valvular Heart Disease Conferences Acute Coronary Syndromes Conferences Cardiac Imaging Conferences Cardiologist Conferences Cardiology Conferences Interventional Cardiology Conferences Peers Alley Media Conferences
The use of stem cell and cell therapy to repair or replace damaged heart tissue is called cardiac regeneration.
There is hope that various tissues or portions of the heart will eventually develop and the ability to regenerate due to the progress in cardiac science and new scientific advances.
Cell Based Heart Repair | Progenitor Cells from the Adult Heart | Human Pluripotent Stem Cell-Derived Cardiomyocytes | Direct Cardiac Reprogramming | Cardiomyocyte Transplantation | Tissue Engineered Heart repair | Imaging Cardiac Stem Cell Therapy | Stem Cell Transplant Immunology | Tissue graft cardiac cell replacement | Cardiac remodeling | Cardiac regenerative therapy | Congenital heart disease and regeneration | Heart repair, heart tissue regeneration and stem cells | Biomimetic heart valve replacement | Stem cell-derived engineered cardiac tissue
The global regenerative medicine market was estimated at USD 27.29 billion in 2020, and it is predicted to increase at a CAGR of 11.27% from 2021 to 2027.
Myocardial Infarction Conferences Cardiology Conferences Atherosclerosis Conferences Interventional Cardiology Conferences Cardio-Oncology Conferences Acute Coronary Syndromes Conferences Cardiovascular Pharmacology Conferences Cardiac Imaging Conferences Peers Alley Media Conferences Cardiology Case Reports Conferences Peers Alley Media Conferences Valvular Heart Disease Conferences Hypertension Conferences Nuclear Cardiology Conferences Electrocardiography Conferences
Dyslipidemia is an increase in blood lipids. The excessive increase in levels of insulin may also lead to dyslipidemia.
LDL Cholesterol | HDL Cholesterol | NON-HDL Cholesterol | High Sensitivity C-Reactive Protein for Risk Assessment | Stratification of Dyslipidemia Risk | Advanced Lipoprotein Testing | Drugs for Treatment of Blood Lipoprotein Abnormalities
The global dyslipidemia drug market was worth US$ 11.8 billion in 2018 and is expected to grow at a CAGR of 3.5% from 2019 to 2027.
North America is the leading contributor to the dyslipidemia medications market. According to the Centers for Disease Control and Prevention (CDC), over 95 million adults in the United States (55% of the population) had total cholesterol levels greater than 200 mg/dL as of 2016. Furthermore, total cholesterol levels higher than 240 mg/dL affect an estimated 29 million adults in the United States.
Cardiology Conferences 2022 Asia Thrombosis Conferences Cardiology Conferences 2022 Australia Dyslipidemia Conferences Electrocardiography Conferences Pediatric Cardiology Conferences Stroke Conferences Interventional Cardiology Conferences Peers Alley Media Conferences Atherosclerosis Conferences Cardiology Conferences 2022 Canada Arrhythmia Conferences Cardio-Oncology Conferences Myocardial Infarction Conferences Heart Diseases in Woman Conferences
Cardiovascular disease (CVD) can be a general term for heart or blood vessel conditions.
It is sometimes associated with an accumulation of fatty deposits in the arteries (atherosclerosis) and an exaggerated risk of blood clots.
It may even be associated with artery injury in organs such as the brain, heart, kidneys, and eyes.
Cardiovascular disease is one of the most common causes of death and disability in the UK of Great Britain and Northern Ireland, but it will usually be prevented by leading a healthy lifestyle.
Endocrine Functions and Metabolic Interactions | Endothelial dysfunction and clinical syndromes | Aging and Cognitive Function | Lipoproteins | Kidney and Hypertension | Atherosclerosis and colonary artery disease | Life style choices, Risk Factors | Diet and Homocysteinemia | Contribution of pollutants and Environmental Chemicals | Genetic Susceptibility | Precautions coronary interventions and Cardiac Surgery | Omega 3 fatty acid in prevention
The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombotic events, is expected to expand from $129.2 billion in 2015 to $146.4 billion by 2022.
The global cardiovascular devices market is expected to grow at a 6.9% CAGR from USD 54.08 billion in 2021 to USD 86.27 billion in 2028.
The global cardiovascular medicines market is predicted to increase at a CAGR of 5.3% from $87.79 billion in 2020 to $92.41 billion in 2021. The increase is primarily due to companies reorganising their operations and recovering from the impact of COVID-19. At a CAGR of 4%, the market is estimated to reach $107.77 billion in 2025.
Geriatric Cardiology Conferences Peers Alley Media Conferences Cardiology Conferences 2022 Canada Cardiology Conferences 2022 Asia Cardiovascular Pharmacology Conferences Cardiac Regeneration Conferences Pulmonology Conferences Vascular Biology Conferences Cardiology Case Reports Conferences Cardiology Conferences 2022 Japan Cardiac Surgery Conferences Robotic Cardiac Surgery Conferences Interventional Cardiology Conferences Heart Diseases in Woman Conferences Nuclear Cardiology Conferences
We depend on the heart's pumping action to provide blood that is rich in nutrients and oxygen to each cell within the body. When cells are not well nourished, the body can not function properly.
The patient is exhausted and breathless if the heart is weakened and can not give enough blood to the cells. It becomes impossible to do everyday activities that were once taken as a privilege.
Heart failure can be a severe condition, and usually there is no remedy. However, the patient will still lead a pleasant, meaningful and productive life with proper treatment.
Epidemiology & pathophysiology of heart failure | Differential Diagnosis of Congestive heart failure | Pharmacologic theraphy of Heart Failure | Clinical approach to acute heart failure | Clinical approach to chronic heart failure | The diagnosis and management of Congestive heart failure
Acute Coronary Syndromes Conferences Peers Alley Media Conferences Cardiology Conferences 2022 Cardiology Conferences 2022 USA Valvular Heart Disease Conferences Heart Diseases in Woman Conferences Arrhythmia Conferences Robotic Cardiac Surgery Conferences Electrocardiography Conferences Cardiologist Conferences Sports Cardiology Conferences Peers Alley Media Conferences Geriatric Cardiology Conferences Thrombosis Conferences Heart Diseases Conferences
Coronary arteries are the portion of the heart muscles in which the blood flow reduces as a result of acute coronary syndromes that fail to function properly. For older patients, chest pain, nausea, vomiting, and diabetes mellitus are the most common symptoms associated with ACS.
ACS is most commonly associated with three clinical manifestations: names according to the Electrocardiogram (ECG) appearance. 1. Myocardial infarction with ST elevation (STEMI, 30 percent), 2. Non-ST myocardial infarction elevation (NSTEMI, 25%) 3. Diagnosis: Different methods of diagnosis • Electrocardiogram • Imaging and blood testing • Scores of prediction
Prevention: Acute coronary syndrome often reflects some degree of atherosclerosis damage to the coronaries. Primary atherosclerosis prevention controls the risk factors: healthy eating, exercise, hypertension and diabetes treatment, avoiding smoking and cholesterol levels; aspirin has been shown to reduce the risk of cardiovascular events in patients with significant risk factors. In myocardial infarction, secondary prevention is discussed.
Following the introduction of a smoking ban in all enclosed public places in Scotland in March 2006, hospital admissions for acute coronary syndrome were reduced by 17 percent. 67% of the decrease occurred in non-smokers.
Treatment: People with presumed ACS are typically treated with nitroglycerin, aspirin, clopidogrel or ticagrelor, and if morphine persists in the chest.
Reduction of Atherothrombosis for Continued Heath | Pathogenesis: Acute Coronary Syndrome | Molecular Mechanisms: Acute Coronary Syndrome | Immune System in Acute Coronary Syndrome | Myocardial Cell Death and Regeneration | Pharmacogenomics | Acute Ischemic Heart Disease | Echocardiography in Acute Coronary Syndrome | Nuclear Cardiology Techniques in Acute Coronary Syndrome | Plaque Passivation and Endothelial Therapy | The Modern Cardiac Unit | Antiplatelet Therapy | Anticoagulants
Arrhythmia Conferences Peers Alley Media Conferences Pediatric Cardiology Conferences Cardiology Conferences 2022 Europe Cardiology Conferences 2022 USA Cardiac Regeneration Conferences Cardiology Case Reports Conferences Cardio-Oncology Conferences Heart Diseases in Woman Conferences Cardiology Conferences 2022 Australia Cardiology Conferences 2022 Canada Clinical Cardiology Conferences Pulmonology Conferences Cardiology Conferences 2022 Interventional Cardiology Conferences
Cardiology is a rapidly evolving subfield of medicine. People in this era, both young and elderly, are vulnerable to cardiac diseases, which are primarily caused by their lifestyle and poor hygiene. To combat these diseases and their causes, the study of cardiology has grown in importance over time. Interventional cardiology is a branch of cardiology that uses minimally invasive procedures to treat diseases with the use of a catheter, allowing doctors and patients to complete the surgery with less blood loss and minimal risk.
Some scientific advances in the fields of sciences, interventional cardiology, and cryopreservation are also predicted to drive the cardiac surgery devices market. The use of expanded Polytetrafluoroethylene for cardiovascular patches, the introduction of transcatheter heart valves, and thus the process of minimally invasive technologies, such as transcatheter semi-lunar valve implantation or transcatheter aortic valve replacement, are just a few of the factors that are expected to drive growth over the forecast period. Furthermore, changes in cryopreservation technologies by key players like CryoLife are among major technological breakthroughs in cardiac surgery therapies that are expected to positively influence the market.
The presence of technologically advanced cardiology and cardiovascular valves, grafts, and patches, as well as an increase in the generality of congenital heart defects, are among the basic variables projected to drive development over the forecast period. During the projection period of 2017-2023, the global market for heart transplants is expected to develop at a CAGR (Compound Annual Growth Rate) of 11.2 percent. The global Interventional Cardiology market is expected to develop slowly at a CAGR of almost 7% during the forecast period. The increased need for minimally invasive (MI) procedures will boost the global interventional cardiology market's growth prospects in the future years.The global interventional cardiology devices market is expected to be worth USD 21.2 billion by 2025, up from USD 13.8 billion in 2020, at an 8.9 percent CAGR during the forecast period. The significant rise in the geriatric population, prevalence of coronary artery diseases, the approval of new and sophisticated products, and thus the rising incidence of diabetes, are all driving growth in this industry.
The Asia Pacific interventional cardiology market is expected to increase at a 7.9 percent CAGR from 2017 to 2023. Cardiac monitoring and diagnostic market size in Asia is 4.5 billion USD in 2015, rising to 6 billion USD in 2017 with an 8% growth rate, and expected to reach 12 billion USD by 2023.
According to the International Diabetes Federation, Asia is home to 60% of the world's diabetes population. Diabetes is one of the leading causes of cardiovascular disease. The rising prevalence of cardiovascular illnesses is the primary driver of market growth in Asia Pacific. Aside from the rising prevalence of diabetes and obesity, changes in lifestyle, more public awareness, and quick technological advancements all contributed to the market's expansion. On the other hand, high cost for manufacturing the devices and a lot of barriers for the course of the new device are the main restraints hampering the market growth.
Cardiology Market in Europe:
The Europe region market for Cardiology management devices, Aortic Repair devices, transcatheter embolization and occlusion devices will grow through 2026, driven by factors such as an ageing population, sedentary lifestyle and changes in food habits, advancements in the field of cardiology as well as an increase in the number of interventional cardiologists, and increasing demand for surgical occlusion devices.
Geographically, North America has the highest market share in 2019 due to increased awareness of gut illnesses. According to the Centers for Disease Control and Prevention (CDC), approximately 610,000 Americans die of heart disease each year. Similarly, 735,000 Americans die of heart attacks each year. Thus, an increase in heart attacks in North America would increase the demand for cardiovascular drugs. However, Asia-Pacific region is predicted to showcase the fastest rate of growth within the future due to the rise in the aging population, increasing awareness and other factors.
Cardiology Market in Middle East:
Countries in the Middle East and Africa bear an important burden from Ischemic heart conditions. Consistent with Dubai Health Authority, heart condition is the cause for each 3 in 10 deaths within the UAE. Huge funding in R&D and various initiatives by the government is driving the expansion of the Ischemic heart condition market in the Middle East and Africa. The Middle-East and Africa Ischemic heart condition market is growing steadily. The market is growing at the CAGR of three .1% and expected to succeed in to US$ 2.84 billion by 2022.
Future Cardiology reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage also will reflect the main technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and knowledge management issues.
Contact us now and we will make your event unique & unforgettable
All numbers indicates percentage %
All numbers indicates percentage %